For Dermatologists & Mohs Surgeons

The Collagen Matrix That's
Built for the Wound Bed
You Actually See.

Omeza Collagen Matrix is FDA 510(k)-cleared and explicitly indicated for post-Mohs surgical wounds — designed to conform to irregular wound beds, protect the site, and support the natural healing process with a simple in-office HCP application.

FDA 510(k) Cleared
Explicitly Indicated for Post-Mohs Surgery
Regular & Irregular Wound Beds
Sterile Single-Use Vial — HCP Applied
510(k)
FDA Cleared wound matrix
for multiple wound types
Post-Mohs
Explicitly listed in the
official IFU indications
4 Phases
Comprehensive wound healing
support in a single product
25 + 58
Subjects across human skin
tolerability studies
About Omeza Collagen Matrix

A Different Approach to Post-Surgical Wound Management

Omeza Collagen Matrix is an amorphous, conforming wound matrix designed for intimate contact with the wound bed. Unlike flat sheet products, OCM is engineered to fit the irregular topography that Mohs surgeons and dermatologists actually encounter — protecting the site and supporting orderly repair from the moment it's applied.

  • Designed to decrease inflammation and support a healthy wound environment
  • Supports proliferation and tissue signaling for organized repair
  • Provides physical scaffolding for skin remodeling
  • Conforms to regular and irregular wound beds intimately
  • Single-use, sterile vial — applied by a physician or licensed HCP
  • Explicitly indicated for post-Mohs surgery in the official IFU

Product description summarized from official IFU and OCM page. IFU   OCM page

Omeza Collagen Matrix product
Comprehensive Wound Healing

Four Phases. One Product.

OCM is positioned to address the key biological needs across all phases of wound healing — something most single-mechanism products cannot provide. Source

01
Protect the Site

Covers the wound and provides a physical barrier and protective environment that supports the natural healing process from the first application.

02
Intimate Contact

Designed for intimate contact with both regular and irregular wound beds — distributed evenly across the wound site for complete coverage.

03
Support Remodeling

Supports proliferation, tissue signaling, and remodeling — providing scaffolding so skin can regrow on an organized structural framework.

04
Reduce Biofilm Impact

Addresses biofilm formation in the wound environment, supporting a cleaner wound bed where healing can progress without interference.

Phase descriptions summarized from official Omeza OCM product page. Source

Official Indications

Explicitly Indicated for Surgical Wounds — Including Post-Mohs.

Omeza's official Instructions for Use list surgical wounds, including post-Mohs surgery, among the product's indicated uses. IFU

✓
Surgical WoundsIncluding donor sites, grafts, post-Mohs surgery, post-laser surgery, podiatric wounds, and wound dehiscence.
✓
Partial- and Full-Thickness WoundsRelevant where clinicians need a matrix designed for direct, intimate contact with the wound bed.
✓
Tunneled or Undermined WoundsImportant when the wound topography is less straightforward or anatomically complex.
✓
Trauma WoundsIncluding abrasions, lacerations, superficial partial-thickness burns, and skin tears.
✓
Draining WoundsUsed in the broader context of wound management where exudate level and dressing choice matter.
✓
Sterile Single-Use FormatSupplied in a sterile vial intended for one-time use by a physician or licensed healthcare professional.
Designed For

Built for Every Surgical Wound Setting

OCM's indication list covers the full spectrum of surgical and complex wound settings.

Mohs Surgeons

Post-excision defects, irregular wound beds, and complex facial anatomy that demand a conforming matrix.

Dermatologists

Surgical wounds, post-laser surgery, skin tears, and venous stasis ulcers in a dermatology office setting.

Plastic Surgeons

Complex reconstructive cases, graft sites, donor sites, and surgical wounds requiring organized wound management.

Wound Care Centers

Chronic and complex wound management at scale, with a product indicated across multiple wound categories.

Podiatrists

Podiatric wounds, diabetic foot ulcers, and post-surgical wound management in the lower extremity setting.

Vascular Surgery

Post-operative wounds, vascular ulcers, wound dehiscence, and complex wound situations following vascular procedures.

General Surgery

Surgical wound management, wound dehiscence, and trauma wounds across a general or hospital-based surgical practice.

Primary Care

Wound management resources for physicians supporting patients with chronic and post-procedural wounds.

Provider Feedback

What Clinicians Are Saying

Feedback from clinicians managing real patients across wound care settings. Source

★★★★★

"Omeza collagen matrix is easily applied, easily maintained and nearly every patient with whom we've used it has gone on to improvement or full healing within the 3rd or 4th application."

Randall Kline, DPM, FACFAS, FAPWCA
Allied Bone and Joint
★★★★★

"After the first two treatments, I was most impressed by the positive qualitative change to the wound bed with robust granulation tissue forming. The wound quickly epithelialized and was healed."

Dr. Michael Lacqua, MD MBA
Medical Director, The Center for Wound Healing
★★★★★

"After 37 years of wound care experience, having tried everything in a wound care center setting, I can only suggest drop what you are using and try Omeza. The results are astounding."

Gregory A. Black, DPM
Sylvania Podiatry, Sylvania, Ohio
★★★★★

"Variable application concept, lidocaine, collagen (matrix), skin protectant, with an easy application process. Amazing results for my patients with chronic non-healing wounds!"

Dr. Anthony J. LaLama
Foot and Ankle Surgeon, Premier Foot & Ankle
★★★★★

"After about three months of using Omeza, I can finally say my patient's wound is healed. The patient's wound had stalled in healing, and this amazing product definitely helped kickstart the healing process."

Oscar Rojas, DPM
Barry University Foot and Ankle Institute
★★★★★

"The response to the Omeza treatment protocol was greater than expected and healed 3 wounds that were present for greater than a year."

Carmen Hudson, MD, FACS, CWSP
Medical Director, United Wound Healing
Safety & Credibility

Safety, Tolerability, and Evidence That Surgeons Need to See.

Omeza's safety program covers human skin testing, repeat insult patch testing, porcine wound-healing studies, sterilization validation, endotoxin testing, viral inactivation work, collagen characterization, and shelf-life data.

The strongest physician-facing message is that OCM is indicated for post-Mohs surgical wounds, designed for intimate wound-bed contact, and supported by safety and bench testing. Product-specific claims around healing speed or cosmesis should be reviewed carefully before use in marketing. Source

25
Subjects in a U.S. skin prick study — no immediate allergic reaction reported under study conditions. Source
58
Subjects in a Human Repeat Insult Patch Test — no side effects observed under study conditions. Source
2
Porcine wound-healing studies — no evidence of impaired healing or adverse biological reactions. Source
Common Questions

Frequently Asked Questions

Written to be conversion-friendly while staying close to official product documentation.

Yes. Omeza's official Instructions for Use list surgical wounds, including post-Mohs surgery, among the product's indicated uses — a direct, on-label statement. Source
Omeza states the matrix is designed for intimate contact with both regular and irregular wound beds — a critical feature in post-Mohs defects, which are rarely flat or uniform. Source
OCM is supplied in a sterile, single-use vial. The IFU describes applying the matrix to a prepared wound bed using aseptic technique, then covering with an appropriate dressing based on wound characteristics and exudate level. Source
Omeza states the product should not be used in patients with known sensitivity to fish collagen or cod liver oil, and is not indicated for third-degree burns. Excessive exudate, bleeding, acute swelling, and infection should be controlled before application. Source
Mohs wound healing can be influenced by wound size and depth, infection, patient comorbidities, surgical technique, and quality of postoperative care. A matrix designed for wound-bed contact and a protective healing environment is clinically relevant across this variable patient population. Source
Broader Mohs collagen literature shows interest in collagen-assisted healing. Omeza's safety testing includes human tolerability studies and porcine wound-healing studies. Product-specific claims around healing speed or cosmetic outcomes should be reviewed by regulatory counsel. PubMed Safety data
Our Team

About Fortify Medical

Fortify Medical is an authorized distributor of Omeza OCM, dedicated to supporting wound care practices nationwide with clinical resources, reimbursement guidance, and direct representative access.

Ben Barton — Medical Consultant, Fortify Medical
Medical Consultant
Ben Barton

Medical Consultant

Heather Bower MBA — Healthcare Administration, Fortify Medical
Healthcare Administration
Heather Bower

M.B.A — Healthcare Administration

Max Cavaliere — Medical Sales Executive, Fortify Medical
Medical Sales Executive
Max Cavaliere

Medical Sales Executive

Authorized Distributor
Committed to Your Practice's Success

Fortify Medical provides product information, clinical resources, reimbursement guidance, and direct representative support to wound care practices nationwide. Our representative, Ben Barton, handles direct practice inquiries with a 24‑hour response commitment.

Ready to Evaluate OCM for Your Practice?

See Whether Omeza Collagen Matrix
Belongs in Your Post-Mohs Protocol.

Start with the product explicitly indicated for post-Mohs surgery — designed for intimate wound-bed contact, protected healing support, and clinician-directed application.

Referenced Sources

Compliance note: This page emphasizes official indications, product description, wound-bed fit, safety/tolerability, and workflow relevance. Any performance claims beyond the official labeling should be reviewed by legal and regulatory counsel before publication. Clinician testimonials are sourced from the official Omeza OCM product page.